A substantial insider sell was reported on May 29, by Walton Family Holdings Trust, 10% Owner at Walmart WMT, based on the recent SEC filing. What Happened: Trust's decision to sell 4,808,020 shares of Walmart was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on ...

On May 29, a recent SEC filing unveiled that Melanie MareinEfron, Chief Financial Officer at Urban Outfitters URBN made an insider sell. What Happened: A Form 4 filing with the U.S.

On May 29, a recent SEC filing unveiled that Azeez Hayne, Chief Administrative Officer at Urban Outfitters URBN made an insider sell. What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Thursday outlined that Hayne executed a sale of 12,856 shares of Urban ...

On May 29, Steven Ortega, Board Member at BJ's Wholesale Club Hldgs BJ executed a significant insider buy, as disclosed in the latest SEC filing. What Happened: A Form 4 filing with the U.S.

Corcept Therapeutics CORT has outperformed the market over the past 5 years by 26.38% on an annualized basis producing an average annual return of 40.21%. Currently, Corcept Therapeutics has a market capitalization of $8.22 billion.

Institutional investors remain hesitant due to Bitcoin's unpredictable swings, preferring safer alternatives like gold. Analysts say the coming 12-18 months will test whether Bitcoin can graduate from risk asset to portfolio hedge.

NEW YORK, May 30, 2025 ( GLOBE NEWSWIRE ) -- Ascendiant Capital Markets LLC ( "Ascendiant" ) publishes equity research coverage on Society Pass Inc. ( Nasdaq: SOPA ) ( "SoPa" or the "Company" ) , Southeast Asia's ( SEA ) next generation, data-driven, loyalty, fintech and e-commerce ecosystem.

Sydney, May 30, 2025 ( GLOBE NEWSWIRE ) -- AI cloud mining is an emerging industry that represents a transformation of traditional mining platforms. As technology matures and the cryptocurrency market evolves, cloud mining has become increasingly dynamic and essential.

MicroStrategy burst onto the crypto scene in 2020 with a bold Bitcoin plan. Now SharpLink wants to do the same-but with Ethereum. Here's what you need to know.

Ivonescimab plus chemo cut disease progression risk by 48% vs. chemo alone ( HR=0.52 ) . Fatal TEAEs were lower with ivonescimab ( 1.8% ) vs. chemo alone ( 2.8% ) in Phase 3 trial. Unlock your all-in-one trading dashboard with real-time alerts, rankings, and stock ideas-60% off ends ...